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  T
he American Medical Student 
Association (AMSA), with more 
than a half-century history of 
medical student activism, is the oldest 
and largest independent association 
of physicians-in-training in the United 
States. As the voice for over 50,000 
members, AMSA has prided itself 
on fostering ideals such as honesty 
and integrity, and on promoting the 
interests of patients and communities. 
    In 2002, when AMSA launched 
its nationwide PharmFree 
campaign to educate medical 
students about the inﬂ  uence of 
the pharmaceutical industry on 
medical training (http:⁄⁄www.amsa.
org/prof/pharmfree.cfm), those 
ideals were being threatened by the 
lavish trips, gifts, and fancy meals 
that pharmaceutical companies 
were providing doctors to change 
their prescribing habits. With one 
pharmaceutical representative for every 
15 practicing doctors [1], many doctors 
began to rely on representatives as 
a quick source of new information 
during their busy days. At the same 
time, most clinical programs lacked 
guidelines for how health-care 
professionals should deal with drug 
representatives [2]. Despite the lack 
of leadership on this issue from the 
mainstream medical community, 
idealistic medical students at AMSA 
rose to the occasion.
  The  PharmFree  Initiative
    In 2002, the leaders of AMSA became 
concerned that the pharmaceutical 
industry’s marketing tactics could 
compromise the personal and 
professional integrity of doctors. The 
PharmFree Initiative began as an 
educational campaign, in collaboration 
with No Free Lunch (http:⁄⁄www.
nofreelunch.org) and Healthy 
Skepticism (http:⁄⁄healthyskepticism.
org), encouraging all physicians-in-
training and health-care providers to 
seek out evidence-based and unbiased 
sources of information, rather than 
relying on industry personnel for 
education. 
    To be a full member of the 
campaign, AMSA encouraged students 
to sign a pledge (Box 1). Students 
who signed the pledge were given 
PharmFree paraphernalia, such as 
pens and badgeholders, to show 
their colleagues and patients that 
they were not being inﬂ  uenced by 
pharmaceutical company promotional 
tactics. 
    In response to the need for unbiased 
information on prescription drugs, 
AMSA forged ties with an independent, 
peer-reviewed nonproﬁ  t organization, 
called The Medical Letter, which 
offers critical evaluation of new drugs 
by authors with no ties to industry 
(http:⁄⁄www.medletter.com). Members 
of AMSA were encouraged to use this 
source and other unbiased sources to 
learn about new drugs. 
    Even before the PharmFree 
campaign began, AMSA had already 
taken steps to ensure that their 
members were not exposed to 
pharmaceutical bias. Since 1978, 
AMSA banned pharmaceutical booths 
in the conference exhibit halls. Its 
monthly publication,   The New Physician  , 
is one of the few medical magazines 
free of pharmaceutical advertising 
(http:⁄⁄www.amsa.org/tnp). 
    While there have been some notable 
campaigns by American medical 
organizations to advise their members 
of the pitfalls of accepting gifts, 
these organizations have themselves 
had close ties with industry, and 
AMSA wanted to avoid such ties. 
For example, in 2005, the American 
College of Physicians published its ﬁ  fth 
edition of its   Ethics Manual   [3], which 
strongly discourages doctors from 
accepting “gifts, hospitality, trips and 
subsidies of all types” from industry. 
Yet the college’s annual meeting is 
heavily sponsored by pharmaceutical 
companies, who pay $60,000 to sponsor 
the meeting’s tote bags and $50,000 
to sponsor the shuttle buses [4]. 
Similarly, when the American Medical 
Association mounted a $1 million 
campaign to educate its members 
about the ethics of accepting gifts 
from industry, most of the campaign’s 
funding came from drug companies 
[5].
    The Impact of PharmFree
    Since its inception, the PharmFree 
campaign has grown steadily and 
has gained recognition in the wider 
medical world. For example, the 
campaign has been cited in the   BMJ 
(British Medical Journal)   and the   Medical 
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  Box 1. The AMSA PharmFree 
Pledge
    “I am committed to the practice of 
medicine in the best interests of patients 
and to the pursuit of education that is 
based on the best available evidence, 
rather than on advertising or promotion. 
    I, therefore, pledge to accept no 
money, gifts, or hospitality from the 
pharmaceutical industry; to seek 
unbiased sources of information and 
not rely on information disseminated by 
drug companies; and to avoid conﬂ  icts 
of interest in my medical education and 
practice.” 
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Journal of Australia   as a voice for 
change in the physician–drug company 
relationship [6,7].
    AMSA inaugurated PharmFree 
Day on December 8th of 2004. This 
was a day where local chapters across 
the country engaged in educational 
talks, recycled drug ads from medical 
journals and sent them back to the 
editors, exchanged pharmaceutical 
company pens for PharmFree pens, 
and “liberated” hospitals by putting 
PharmFree stickers (Figure 1) over all 
the pharmaceutical logos that could 
be found (on pens, clocks, clipboards, 
etc). The day climaxed at the world 
headquarters of Pﬁ  zer, where students 
demonstrated and returned the 
pharmaceutical paraphernalia they 
had collected at their local chapters 
through a nationwide pen amnesty 
program (http:⁄⁄www.amsa.org/news/
focus/0305news.cfm). Pﬁ  zer’s only 
response to these actions was calling 
the police, who allowed the protest to 
proceed because it was conducted on 
public property.
    But there is still much work to be 
done to educate American medical 
students about the inﬂ  uence of 
industry marketing tactics. A recent 
national US survey of 1,143 third-year 
medical students, which had a response 
rate of 72.3%, found a mean exposure 
to pharmaceutical company gifts or 
sponsored events of one gift or event 
per week. It also found that most 
students believed they were entitled to 
gifts [8].
  The  Future 
    The next step for the PharmFree 
campaign is the Counterdetailing 
Initiative, which will allow students 
to transform their passion for being 
PharmFree into grassroots activism. 
(“Detailing” is a term that describes 
the practice pharmaceutical companies 
use to educate doctors about their 
newest products through drug 
representatives.) AMSA members will 
be visiting doctor’s ofﬁ  ces distributing 
information sheets about unbiased 
sources of information, much like 
the way drug representatives “detail” 
doctors. Students who are on the wards 
can also participate by distributing 
pocket cards to their colleagues at 
drug company–sponsored events. In 
addition to encouraging our members 
to “just say no” to free lunch, AMSA 
is providing them with the tools to 
“counterdetail” drug representatives. 
Of course, our numbers pale in 
comparison to drug detailers, but 
“counterdetailing” is a symbolic gesture 
to show that we as medical students 
should be getting our information on 
new drugs from unbiased sources. 
    For more information on becoming 
a counterdetailer or on the PharmFree 
campaign, see http:⁄⁄www.amsa.org/
prof/pharmfree.cfm. It is time for 
medical students around the world to 
revitalize the professionalism essential 
to being a doctor.   
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  Figure 1.   Promotional Material for AMSA’s PharmFree Day   
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